Alprostadil Liposomes for Injection for Lower Extremity Arteriosclerosis Obliteran

NCT04197323 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Artery Disease

Interventions

DRUG: Alprostadil liposomes for injection

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.